• (11th November, 2014); Pharma Major Lupin Limited (Lupin) announced that it has received final approval for its Celecoxib Capsules, 50 mg from the United States Food and Drugs Administration (FDA) to market a generic version of G.D. Searle LLC’s (a subsidiary of Pfizer Inc.) Celebrex® Capsules 50 mg. Lupin also received tentative approvals for its Celecoxib capsules 100 mg, 200 mg and 400 mg strengths from the FDA.

  • Work as Sr. Executive-Process Development in Lupin Pharmaceuticals
    9 April 2012
    Work as Sr. Executive-Process Development in Lupin Pharmaceuticals

    Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top six pharmaceutical companies in India. Through our sales and marketing headquarters in Baltimore, MD, Lupin Pharmaceuticals, Inc.

  • Freshers invited for Walk in Interview for the post of Marketing Trainees/Executive and Medical Representative in Lupin Pharma
    13 March 2012
    Freshers invited for Walk in Interview for the post of Marketing Trainees/Executive and Medical Representative in Lupin Pharma

    Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations and APIs for the developed and developing markets of the world. The Company today has significant market share in key markets in the Cardiovascular, Diabctology, Asthma, Pediatrics, CNS, GI, Anti-Infectives and NSAIDs therapy segments, not to mention global leadership positions in the Anti-TB and Cephalosporins segments.

  • Require Officer Quality Control with Pharma API & Bulk Drugs in Lupin Pharma - 5 vacancies
    12 January 2012
    Require Officer Quality Control with Pharma API & Bulk Drugs in Lupin Pharma - 5 vacancies

  • Walk in @ Lupin Pharma | Apply for Jr. Officer/Officer - Production, Officer/Executive -QA/QC
    16 November 2011
    Walk in @ Lupin Pharma | Apply for Jr. Officer/Officer - Production, Officer/Executive -QA/QC

    Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top six pharmaceutical companies in India. Through our sales and marketing headquarters in Baltimore, MD, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies.

  • Senior Officer - Process Development Lab Require in Lupin Pharma
    23 October 2011
    Senior Officer - Process Development Lab Require in Lupin Pharma

    Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top six pharmaceutical companies in India. Through our sales and marketing headquarters in Baltimore, MD, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies.

  • Job as Officer / Senior Officer - Production in Lupin Pharma
    18 October 2011
    Job as Officer / Senior Officer - Production in Lupin Pharma

  • Walk in as Marketing Trainees / Executives & Medical Representative @ Lupin Pharma | Multiplace vacancies - Freshers can apply
    13 October 2011
    Walk in as Marketing Trainees / Executives & Medical Representative @ Lupin Pharma | Multiplace vacancies - Freshers can apply

    Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top six pharmaceutical companies in India. Through our sales and marketing headquarters in Baltimore, MD, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies.

  • Eli Lilly India (Lilly) and Lupin Limited (Lupin) Announced Strategic Collaboration to Help Fight the Battle Against Diabetes
    3 September 2011
    Eli Lilly India (Lilly) and Lupin Limited (Lupin) Announced Strategic Collaboration to Help Fight the Battle Against Diabetes

    Eli Lilly India (Lilly) and Lupin Limited (Lupin) announced on 29th July, 2011 that they have entered into a strategic collaboration to promote and distribute Lilly’s Huminsulin range of products, including Huminsulin RTM, Huminsulin NPHTM, Huminsulin 50/50TM, Huminsulin 30/70TM and Humapen Ergo II. Lupin’s India formulations business will promote and distribute the range of products in India and Nepal, virtually doubling the number of sales representatives behind the diabetes care product.

  • Lupin Receives Final Approval to Market Generic Ultram® ER from US FDA
    2 September 2011
    Lupin Receives Final Approval to Market Generic Ultram® ER from US FDA

    Lupin Pharmaceuticals, Inc. (LPI) announced on 29th aug, 2011 that it has received final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Tramadol Hydrochloride Extended-Release Tablets, 100, 200 and 300 mg strengths. Lupin will begin shipping its Tramadol ER shortly.

Subscribe to Lupin Pharma